12:30-1:00 PM Registration
12:50-1:00 PM Welcome & Meeting Acknowledgements
Ted Krafczyk, M.S. - Director WV SCACM
1:00-2:00 PM 1.0 Contact Hour; Level Basic to Intermediate; PACE # 362-028-07
Hepatitis Soup
Patricia Canfield, M.D.–Medical Laboratory Director, West Virginia University Hospitals Clinical Laboratories
Objectives: At the conclusion of the presentation, participants will be able to:
1. Understand the basic differences between the various types of viral hepatitis in the clinical presentations
2. Know the testing available for a viral hepatitis
3. Interpret test results from looking at viral hepatitis panels
4. Guide fellow coworkers in the prevention of viral hepatitis
2:00-2:30 PM Break
2:30-4:00 PM 1.5 Contact Hour; Level Intermediate; PACE # 362-029-07
Critical Situations in Clinical Microbiology
James W. Snyder, Ph.D., D(ABMM), F(AAM) – University of Louisville
Objectives: At the conclusion of the presentation, participants will be able to:
1. Understand the structure and integration of the Sentinel Level Laboratory with the Laboratory Response Network
2. Assess the need for antifungal susceptibility testing and its important patient management
3. Apply the current recommended method for the detection of carbapenem resistant Klebsiella pneumonia
7:30-8:00 AM Registration & Continental Breakfast
7:50-8:00 AM Welcome & Meeting
Ted Krafczyk, M.S. - Director WV SCACM
8:00-9:00 AM 1.0 Contact Hour; Level Basic; PACE # 362-030-07
Molecular Microbiology for the Molecularly Challenged
Duane W. Newton , Ph.D., D(ABMM) – Director, Clinical Microbiology Laboratories, University of Michigan Health System
Objectives: At the conclusion of the presentation, participants will be able to:
1. Describe basic concepts of molecular biology
2. Describe various methods for nucleic acid extraction and detection
3. Discuss new molecular methods that are being implemented in clinical microbiology laboratories
9:000-10:00 AM 1.0 Contact Hour; Level Basic; PACE # 362-031-07
Infectious Disease Case Histories
Danae Bixler, M.D., MPH – Director, Infectious Disease/Epidemiology West Virginia Health and Human Resources
Objectives: At the conclusion of the presentation, participants will be able to:
1. Understand outbreak investigation in West Virginia through the use of case histories
2. Understand all aspects of outbreak investigation: outbreak recognition, case ascertainment and case finding, and hypothesis testing
3. Understand the role the laboratory plays in all the aspects of outbreak investigation
10:00-10:45 AM Break & Visit the Exhibits
10:45-12:00 PM 1 Contact Hour; Level Intermediate; PACE # 362-032-07
Correct Coding in Clinical Microbiology: Concepts and Cases
Vickie Baselski, Ph.D., DABMM, FAAM – Professor of Pathology, University of Tennessee Health Sciences Center , Memphis , TN 38163
Objectives: At the conclusion of the presentation, participants will be able to:
1. To review the importance of correct coding in documenting work load and obtaining reimbursement
2. To identify rules and regulations that influence correct procedure coding in infectious disease diagnostics
3. To present frequently asked questions and answers regarding correct coding using case scenarios
12:00-1:30 PM Lunch & Visit the Exhibits
1:30-2:30 PM 1.0 Contact Hour; Level Intermediate; PACE #362-033-07
Update on the Incidence, Epidemiology and Surveillance for MRSA In 2007
Gerri S. Hall, Ph.D., D(ABMM) – Cleveland Clinic Staff Microbiologist
Objectives: At the conclusion of the presentation, participants will be able to:
1. Define the epidemiology and incident of hospital acquired MRSA in 2007
2. List the methods used for surveillance of MRSA from clinical specimens directly
3. Describe the most recent recommendations for MRSA surveillance and how they are being implemented
2:30-3:00 PM Break
3:00-4:00 PM 1.0 Contact Hour; Level Intermediate; PACE # 362-034-07
Screening for Intestinal Inflammation Using Rapid Diagnostics; Is It Useful?
James H. Boone, M.S. – Senior Research Scientist, TechLab, Inc.
Objectives: At the conclusion of the presentation, participants will be able to:
1. Know the differences between inflammatory and noninflammatory diarrheal diseases
2. Discuss the diagnostic utility for determining the presence of intestinal inflammation
3. Review the rapid stool-based immunoassays for fecal leukocytes
For further information contact:
Ted Krafczyk, West Virginia University Hospitals Clinical Laboratories
One Medical Center Drive , Morgantown , WV 26506
Phone: (304) 598-4243 Fax: (304) 598-4166
Email: krafczykt@wvuh.com